Inside of a screening examination involving in excess of 240 receptors, the scientists found that conolidine demonstrated binding on the ACKR3 receptor in both of those humans and mice, avoiding ACKR3 from binding to opioid peptides. It acts via a pure mechanism to assist the human body regul